Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis. Brown J, William L, Coles AJ Drug Des Devel Ther. 2013; 7:131-8. Epub 2013 Mar 06. PMID: 23494602. Abstract CommentRecommendBookmarkWatch